Clinical Trial Update: Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® [NA]

View source ↗

Summary

The multicenter trial evaluating the performance and safety of the SiPore21 device in adults with overweight or obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SiPore21

Snippet

Sponsor: Sigrid Therapeutics AB | Conditions: Overweight or Obesity | NA | Status: COMPLETED